ADRB1 and familial dilated cardiomyopathy: In this regard, major problems could arise from the questionable validity of peptide-based ELISA strategies in the diagnostics of cardio-pathogenic AAbs that activate GPCRs because detection of DCM-associated β1AR-AAbs requires functional readouts or native human β1AR as targets [63,103,104,105].